Thomas E. Smithgall - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Molecular Biology, Oncology, Biochemistry

162 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Peng WY, Abere B, Shi H, Toland S, Smithgall TE, Moore PS, Chang Y. Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through Src-family kinases. Proceedings of the National Academy of Sciences of the United States of America. 120: e2316467120. PMID 38079542 DOI: 10.1073/pnas.2316467120  0.361
2023 Emert-Sedlak LA, Tice CM, Shi H, Alvarado JJ, Shu ST, Reitz AB, Smithgall TE. PROTAC-mediated Degradation of HIV-1 Nef Efficiently Restores Cell-surface CD4 and MHC-I Expression and Blocks HIV-1 Replication. Biorxiv : the Preprint Server For Biology. PMID 37645900 DOI: 10.1101/2023.08.14.553289  0.345
2023 Heinrich F, Thomas CE, Jeff Alvarado J, Eells R, Thomas A, Doucet M, Whitlatch KN, Aryal M, Lösche M, Smithgall TE. Neutron Reflectometry and Molecular Simulations Demonstrate HIV-1 Nef Homodimer Formation on Model Lipid Bilayers. Journal of Molecular Biology. 168009. PMID 36773691 DOI: 10.1016/j.jmb.2023.168009  0.317
2022 Emert-Sedlak LA, Shi H, Tice CM, Chen L, Alvarado JJ, Shu ST, Du S, Thomas CE, Wrobel JE, Reitz AB, Smithgall TE. Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor. Viruses. 14. PMID 36146831 DOI: 10.3390/v14092025  0.326
2022 Aryal M, Lin D, Regan K, Du S, Shi H, Alvarado JJ, Ilina TV, Andreotti AH, Smithgall TE. The HIV-1 protein Nef activates the Tec family kinase Btk by stabilizing an intermolecular SH3-SH2 domain interaction. Science Signaling. 15: eabn8359. PMID 36126115 DOI: 10.1126/scisignal.abn8359  0.534
2022 Du S, Alvarado JJ, Wales TE, Moroco JA, Engen JR, Smithgall TE. ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase, Fgr. Structure (London, England : 1993). PMID 36115344 DOI: 10.1016/j.str.2022.08.008  0.427
2022 Emert-Sedlak LA, Moukha-Chafiq O, Shi H, Du S, Alvarado JJ, Pathak V, Tanner SG, Hunter RN, Nebane M, Chen L, Ilina TV, Ishima R, Zhang S, Kuzmichev YV, Wonderlich ER, ... ... Smithgall TE, et al. Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation. Acs Infectious Diseases. PMID 34985256 DOI: 10.1021/acsinfecdis.1c00288  0.405
2021 Shu ST, Li WF, Smithgall TE. Visualization of Host Cell Kinase Activation by Viral Proteins Using GFP Fluorescence Complementation and Immunofluorescence Microscopy. Bio-Protocol. 11: e4068. PMID 34327265 DOI: 10.21769/BioProtoc.4068  0.454
2020 Staudt RP, Smithgall TE. Nef Homodimers Downregulate SERINC5 by AP-2-Mediated Endocytosis to Promote HIV-1 Infectivity. The Journal of Biological Chemistry. PMID 32873704 DOI: 10.1074/Jbc.Ra120.014668  0.435
2020 Staudt RP, Alvarado JJ, Emert-Sedlak LA, Shi H, Shu ST, Wales TE, Engen JR, Smithgall TE. Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes. The Journal of Biological Chemistry. PMID 32862141 DOI: 10.1074/Jbc.Rev120.012317  0.519
2020 Patel RK, Patel YK, Smithgall TE. Evolution Reveals a Single Mutation as Sole Source of Src-Family Kinase C-Helix-out Inhibitor Resistance. Acs Chemical Biology. PMID 32602694 DOI: 10.1021/Acschembio.0C00373  0.491
2020 Li WF, Aryal M, Shu ST, Smithgall TE. HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane. The Journal of Biological Chemistry. PMID 32144207 DOI: 10.1074/Jbc.Ra120.012536  0.556
2019 Dorman HR, Close D, Wingert BM, Camacho CJ, Johnston PA, Smithgall TE. Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck. Frontiers in Chemistry. 7: 822. PMID 31850311 DOI: 10.3389/Fchem.2019.00822  0.543
2019 Patel RK, Weir MC, Shen K, Snyder D, Cooper VS, Smithgall TE. Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance. Plos One. 14: e0225887. PMID 31790499 DOI: 10.1371/Journal.Pone.0225887  0.498
2019 Shi HE, Tice CM, Emert-Sedlak LA, Chen L, Li WF, Carlsen M, Wrobel JE, Reitz AB, Smithgall TE. Tight-binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-mediated MHC-I downregulation. Acs Infectious Diseases. PMID 31775511 DOI: 10.1021/Acsinfecdis.9B00382  0.492
2019 Kall SL, Whitlatch K, Smithgall TE, Lavie A. Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase. Scientific Reports. 9: 17121. PMID 31745227 DOI: 10.1038/S41598-019-53447-0  0.499
2019 Kervick C, Aryal M, Heinrich F, Smithgall TE, Lösche M. Membrane Binding of HIV-1 Accessory Protein Nef on Sparsely-Tethered Bilayer Lipid Membranes: An Spr Study Biophysical Journal. 116: 57a. DOI: 10.1016/J.Bpj.2018.11.350  0.335
2018 Shen K, Moroco JA, Patel RK, Shi H, Engen JR, Dorman HR, Smithgall TE. The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation. Science Signaling. 11. PMID 30352950 DOI: 10.1126/Scisignal.Aat5916  0.447
2018 Weir MC, Shu ST, Patel RK, Hellwig S, Chen L, Tan L, Gray NS, Smithgall TE. Selective inhibition of the myeloid Src-family kinase Fgr potently suppresses AML cell growth in vitro and in vivo. Acs Chemical Biology. PMID 29763550 DOI: 10.1021/Acschembio.8B00154  0.392
2018 Shi J, Xiong R, Zhou T, Su P, Zhang X, Qiu X, Li H, Li S, Yu C, Wang B, Ding C, Smithgall TE, Zheng YH. HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system. Journal of Virology. PMID 29514909 DOI: 10.1128/JVI.00196-18  0.318
2018 Wu M, Alvarado JJ, Augelli-Szafran CE, Ptak RG, Smithgall TE. A single β-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding. Plos One. 13: e0192512. PMID 29415006 DOI: 10.1371/journal.pone.0192512  0.383
2018 Eells R, Whitlatch K, Treece B, Heinrich F, Jeff Alvarado J, Smithgall TE, Lösche M. Membrane Bound Structure of the HIV-1 Accessory Protein Nef Biophysical Journal. 114: 33a. DOI: 10.1016/J.Bpj.2017.11.226  0.389
2017 Moroco JA, Alvarado JJ, Staudt RP, Shic H, Wales TE, Smithgall TE, Engen JR. Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding. Journal of Molecular Biology. PMID 29258818 DOI: 10.1016/J.Jmb.2017.12.008  0.463
2017 Advani G, Lim YC, Catimel B, Lio DSS, Ng NLY, Chüeh AC, Tran M, Anasir MI, Verkade H, Zhu HJ, Turk BE, Smithgall TE, Ang CS, Griffin M, Cheng HC. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Cell Communication and Signaling : Ccs. 15: 29. PMID 28784162 DOI: 10.1186/S12964-017-0186-X  0.445
2017 Weir MC, Hellwig S, Tan L, Liu Y, Gray NS, Smithgall TE. Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth. Plos One. 12: e0181178. PMID 28727840 DOI: 10.1371/Journal.Pone.0181178  0.324
2017 Tan R, Nakajima S, Wang Q, Sun H, Xue J, Wu J, Hellwig S, Zeng X, Yates NA, Smithgall TE, Lei M, Jiang Y, Levine AS, Su B, Lan L. Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1. Molecular Cell. PMID 28216227 DOI: 10.1016/J.Molcel.2017.01.015  0.337
2017 Weir MC, Shu S, Hellwig S, Patel R, Chen L, Tan L, Gray N, Smithgall T. A Unique N-Phenylbenzamide Inhibitor Targeting Non-Receptor Tyrosine Kinases Potently Suppresses AML Cell Growth In Vitro and In Vivo Blood. 130: 3813-3813. DOI: 10.1182/Blood.V130.Suppl_1.3813.3813  0.427
2017 Shen K, Dorman HR, Shi H, Patel RK, Moroco JA, Engen JR, Smithgall TE. Abstract 2377: The AML linked Src family kinase Fgr is uncoupled from SH2 and SH3 domain regulation and drives oncogenic transformation Cancer Research. 77: 2377-2377. DOI: 10.1158/1538-7445.Am2017-2377  0.461
2017 Patel RK, Weir M, Hellwig S, Dorman H, Smithgall TE. Abstract 2363: Targeting Src-family kinases to combat acquired inhibitor resistance in FLT3-ITD+AML Cancer Research. 77: 2363-2363. DOI: 10.1158/1538-7445.Am2017-2363  0.422
2017 Eells R, Whitlatch K, Heinrich F, Lösche M, Smithgall TE. Progress Towards a Membrane-Bound Structure of the ITK/NEF Complex Biophysical Journal. 112: 378a. DOI: 10.1016/J.Bpj.2016.11.2055  0.541
2016 Shu ST, Emert-Sedlak LA, Smithgall TE. Cell-based Fluorescence Complementation Reveals a Role for HIV-1 Nef Dimerization in AP-2 Recruitment and CD4 downregulation. The Journal of Biological Chemistry. PMID 28031466 DOI: 10.1074/Jbc.M116.770016  0.352
2016 Badger J, Grover P, Panjarian SB, Engen JR, Smithgall TE, Makowski L. The c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution. Biochemistry. PMID 27166638 DOI: 10.1021/Acs.Biochem.6B00202  0.814
2016 Wales TE, Poe JA, Emert-Sedlak L, Morgan CR, Smithgall TE, Engen JR. Hydrogen Exchange Mass Spectrometry of Related Proteins with Divergent Sequences: A Comparative Study of HIV-1 Nef Allelic Variants. Journal of the American Society For Mass Spectrometry. PMID 27032648 DOI: 10.1007/S13361-016-1365-5  0.786
2016 Emert-Sedlak LA, Loughran HM, Shi H, Kulp JL, Shu ST, Zhao J, Day BW, Wrobel JE, Reitz AB, Smithgall TE. Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists. Bioorganic & Medicinal Chemistry Letters. 26: 1480-4. PMID 26852364 DOI: 10.1016/J.Bmcl.2016.01.043  0.457
2016 Roberts JM, Tarafdar S, Joseph RE, Andreotti AH, Smithgall TE, Engen JR, Wales TE. Dynamics of the Tec-family Tyrosine Kinase SH3 domains. Protein Science : a Publication of the Protein Society. PMID 26808198 DOI: 10.1002/Pro.2887  0.729
2015 Wales TE, Hochrein JM, Morgan CR, Emert-Sedlak LA, Smithgall TE, Engen JR. Subtle Dynamic Changes Accompany Hck Activation by HIV-1 Nef and are Reversed by an Antiretroviral Kinase Inhibitor. Biochemistry. 54: 6382-91. PMID 26440750 DOI: 10.1021/Acs.Biochem.5B00875  0.514
2015 Grover P, Shi H, Baumgartner M, Camacho CJ, Smithgall TE. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function. Plos One. 10: e0133590. PMID 26222440 DOI: 10.1371/Journal.Pone.0133590  0.452
2015 Pirrone GF, Emert-Sedlak LA, Wales TE, Smithgall TE, Kent MS, Engen JR. Membrane-Associated Conformation of HIV-1 Nef Investigated with Hydrogen Exchange Mass Spectrometry at a Langmuir Monolayer. Analytical Chemistry. PMID 26133569 DOI: 10.1021/Acs.Analchem.5B01725  0.331
2015 Moroco JA, Baumgartner MP, Rust HL, Choi HG, Hur W, Gray NS, Camacho CJ, Smithgall TE. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region. Chemical Biology & Drug Design. 86: 144-55. PMID 25376742 DOI: 10.1111/Cbdd.12473  0.432
2015 Weir M, Hellwig S, Gray NS, Smithgall TE. Abstract A25: Dual inhibition of Flt3 and Fes tyrosine kinases potently blocks proliferation of AML cells expressing an active Flt3 mutant. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-A25  0.47
2015 Rust HL, Moroco JA, Alvarado JJ, Engen JJ, Smithgall TE. Abstract B190: Allosteric modulation of Src family kinases via SH3 domain displacement Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B190  0.559
2015 Weir MC, Hellwig S, Patel R, Gray NS, Smithgall TE. Abstract B180: Multi-targeted tyrosine kinase inhibitors potently suppress FLT3-ITD+ AML cell growth Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B180  0.521
2015 Grover P, Shi H, Baumgartner M, Close D, Johnston PA, Camacho CJ, Smithgall TE. Abstract B132: Discovery of small molecule allosteric modulators of Abl kinase activity and function Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B132  0.566
2014 Zhang X, Simerly C, Hartnett C, Schatten G, Smithgall TE. Src-family tyrosine kinase activities are essential for differentiation of human embryonic stem cells. Stem Cell Research. 13: 379-89. PMID 25305536 DOI: 10.1016/J.Scr.2014.09.007  0.451
2014 Moroco JA, Craigo JK, Iacob RE, Wales TE, Engen JR, Smithgall TE. Differential sensitivity of Src-family kinases to activation by SH3 domain displacement. Plos One. 9: e105629. PMID 25144189 DOI: 10.1371/Journal.Pone.0105629  0.474
2014 Alvarado JJ, Tarafdar S, Yeh JI, Smithgall TE. Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment. The Journal of Biological Chemistry. 289: 28539-53. PMID 25122770 DOI: 10.1074/Jbc.M114.600031  0.787
2014 Tarafdar S, Poe JA, Smithgall TE. The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner. The Journal of Biological Chemistry. 289: 15718-28. PMID 24722985 DOI: 10.1074/Jbc.M114.572099  0.831
2014 Iyer PC, Zhao J, Emert-Sedlak LA, Moore KK, Smithgall TE, Day BW. Synthesis and structure-activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor. Bioorganic & Medicinal Chemistry Letters. 24: 1702-6. PMID 24650642 DOI: 10.1016/J.Bmcl.2014.02.045  0.478
2014 Poe JA, Vollmer L, Vogt A, Smithgall TE. Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization Journal of Biomolecular Screening. 19: 556-565. PMID 24282155 DOI: 10.1177/1087057113513640  0.803
2014 Zhang X, Meyn MA, Smithgall TE. c-Yes tyrosine kinase is a potent suppressor of ES cell differentiation and antagonizes the actions of its closest phylogenetic relative, c-Src. Acs Chemical Biology. 9: 139-46. PMID 23895624 DOI: 10.1021/Cb400249B  0.335
2014 Grover P, Smithgall TE. Abstract 3728: A discovery platform for allosteric modulators of c-Abl kinase function Cancer Research. 74: 3728-3728. DOI: 10.1158/1538-7445.Am2014-3728  0.55
2013 Smithgall TE, Thomas G. Small molecule inhibitors of the HIV-1 virulence factor, Nef. Drug Discovery Today. Technologies. 10: e523-9. PMID 24451644 DOI: 10.1016/J.Ddtec.2013.07.002  0.407
2013 Trible RP, Narute P, Emert-Sedlak LA, Alvarado JJ, Atkins K, Thomas L, Kodama T, Yanamala N, Korotchenko V, Day BW, Thomas G, Smithgall TE. Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen. Retrovirology. 10: 135. PMID 24229420 DOI: 10.1186/1742-4690-10-135  0.811
2013 Perrone R, Nadai M, Poe JA, Frasson I, Palumbo M, Palù G, Smithgall TE, Richter SN. Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity. Plos One. 8: e73121. PMID 24015290 DOI: 10.1371/Journal.Pone.0073121  0.784
2013 Perrone R, Nadai M, Frasson I, Poe JA, Butovskaya E, Smithgall TE, Palumbo M, Palù G, Richter SN. A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter. Journal of Medicinal Chemistry. 56: 6521-30. PMID 23865750 DOI: 10.1021/Jm400914R  0.79
2013 Engen JR, Wales TE, Chen S, Marzluff EM, Hassell KM, Weis DD, Smithgall TE. Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry. International Reviews in Physical Chemistry. 32: 96-127. PMID 23682200 DOI: 10.1080/0144235X.2012.751175  0.407
2013 Emert-Sedlak LA, Narute P, Shu ST, Poe JA, Shi H, Yanamala N, Alvarado JJ, Lazo JS, Yeh JI, Johnston PA, Smithgall TE. Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chemistry & Biology. 20: 82-91. PMID 23352142 DOI: 10.1016/J.Chembiol.2012.11.005  0.817
2013 Panjarian S, Iacob RE, Chen S, Engen JR, Smithgall TE. Structure and dynamic regulation of Abl kinases. The Journal of Biological Chemistry. 288: 5443-50. PMID 23316053 DOI: 10.1074/Jbc.R112.438382  0.779
2013 Panjarian S, Iacob RE, Chen S, Wales TE, Engen JR, Smithgall TE. Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors. The Journal of Biological Chemistry. 288: 6116-29. PMID 23303187 DOI: 10.1074/Jbc.M112.431312  0.802
2013 O'Reilly LP, Zhang X, Smithgall TE. Individual Src-family tyrosine kinases direct the degradation or protection of the clock protein Timeless via differential ubiquitylation. Cellular Signalling. 25: 860-6. PMID 23266470 DOI: 10.1016/J.Cellsig.2012.12.009  0.474
2013 Panjarian SB, Iacob R, Shugui C, Wales T, Engen JR, Smithgall TE. Abstract 2221: Enhanced SH3:linker interaction allosterically sensitizes Abl kinases to small molecule inhibitors. Cancer Research. 73: 2221-2221. DOI: 10.1158/1538-7445.Am2013-2221  0.813
2013 Weir M, Hellwig S, Gray NS, Smithgall TE. Abstract 2086: Dual inhibitors of Flt3 and c-Fest tyrosine kinases potently inhibit proliferation of AML cells expressing an active Flt3 mutant. Cancer Research. 73: 2086-2086. DOI: 10.1158/1538-7445.Am2013-2086  0.435
2012 Hellwig S, Miduturu CV, Kanda S, Zhang J, Filippakopoulos P, Salah E, Deng X, Choi HG, Zhou W, Hur W, Knapp S, Gray NS, Smithgall TE. Small-molecule inhibitors of the c-Fes protein-tyrosine kinase. Chemistry & Biology. 19: 529-40. PMID 22520759 DOI: 10.1016/J.Chembiol.2012.01.020  0.413
2012 Pene-Dumitrescu T, Shu ST, Wales TE, Alvarado JJ, Shi H, Narute P, Moroco JA, Yeh JI, Engen JR, Smithgall TE. HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck. Bmc Chemical Biology. 12: 1. PMID 22420777 DOI: 10.1186/1472-6769-12-1  0.624
2012 Narute PS, Smithgall TE. Nef alleles from all major HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner. Plos One. 7: e32561. PMID 22393415 DOI: 10.1371/journal.pone.0032561  0.462
2012 Greer PA, Kanda S, Smithgall TE. The contrasting oncogenic and tumor suppressor roles of FES. Frontiers in Bioscience (Scholar Edition). 4: 489-501. PMID 22202072 DOI: 10.2741/280  0.388
2012 Moroco JA, Gray NS, Smithgall TE. Abstract 861: Selective small-molecule kinase inhibitors of the c-Src:FAK complex Cancer Research. 72: 861-861. DOI: 10.1158/1538-7445.Am2012-861  0.524
2012 Panjarian SB, Chen S, Iacob R, Wales T, Engen JR, Smithgall TE. Abstract 5599: Allosteric regulation of Abl and Bcr-Abl kinases by enhanced SH3:linker interaction Cancer Research. 72: 5599-5599. DOI: 10.1158/1538-7445.Am2012-5599  0.819
2012 Moroco J, Craigo J, Gray N, Smithgall T. 225 Diversity in Individual Src-family Kinase Regulation: Opportunities for Selective Inhibitor Discovery European Journal of Cancer. 48: 68. DOI: 10.1016/S0959-8049(12)72023-3  0.435
2011 Marcsisin SR, Narute PS, Emert-Sedlak LA, Kloczewiak M, Smithgall TE, Engen JR. On the solution conformation and dynamics of the HIV-1 viral infectivity factor. Journal of Molecular Biology. 410: 1008-22. PMID 21763503 DOI: 10.1016/J.Jmb.2011.04.053  0.482
2011 Hellwig S, Smithgall TE. Structure and regulation of the c-Fes protein-tyrosine kinase. Frontiers in Bioscience (Landmark Edition). 16: 3146-55. PMID 21622225 DOI: 10.2741/3902  0.464
2011 O'Reilly LP, Watkins SC, Smithgall TE. An unexpected role for the clock protein timeless in developmental apoptosis. Plos One. 6: e17157. PMID 21359199 DOI: 10.1371/Journal.Pone.0017157  0.378
2011 Panjarian SB, Chen S, Iacob R, Wales TE, Engen JR, Smithgall TE. Abstract B75: Allosteric regulation of Abl and Bcr-Abl kinases by enhanced SH3:linker interaction. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B75  0.821
2011 Hellwig S, Gray NS, Smithgall TE. Abstract A234: Identification and characterization of inhibitor-resistant mutants of the protein-tyrosine kinase c-Fes. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A234  0.51
2010 Alvarado JJ, Betts L, Moroco JA, Smithgall TE, Yeh JI. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism. The Journal of Biological Chemistry. 285: 35455-61. PMID 20810664 DOI: 10.1074/Jbc.M110.145102  0.557
2010 Dikeakos JD, Atkins KM, Thomas L, Emert-Sedlak L, Byeon IJ, Jung J, Ahn J, Wortman MD, Kukull B, Saito M, Koizumi H, Williamson DM, Hiyoshi M, Barklis E, Takiguchi M, ... Smithgall TE, et al. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Molecular Biology of the Cell. 21: 3279-92. PMID 20702582 DOI: 10.1091/Mbc.E10-05-0470  0.495
2010 Pene-Dumitrescu T, Smithgall TE. Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner. The Journal of Biological Chemistry. 285: 21446-57. PMID 20452982 DOI: 10.1074/jbc.M109.090043  0.368
2010 Qu Z, Yan P, Fu J, Jiang J, Grusby MJ, Smithgall TE, Xiao G. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Research. 70: 1766-72. PMID 20145149 DOI: 10.1158/0008-5472.Can-09-3263  0.332
2010 Panjarian S, Chen S, Engen J, Smithgall T. Enhanced SH3:Linker Interaction Suppresses Activating Mutations of the c-Abl Protein-Tyrosine Kinase. Blood. 116: 1208-1208. DOI: 10.1182/Blood.V116.21.1208.1208  0.812
2010 Panjarian S, Smithgall TE. Abstract 632: Cross-resistance of myeloid cells transformed with Bcr-Abl imatinib-resistant mutant T315I to Src-family kinase inhibitors Cancer Research. 70: 632-632. DOI: 10.1158/1538-7445.Am10-632  0.757
2010 Hellwig S, Smithgall TE. Abstract 4171: The role of the Src kinase family in determining three-dimensional epithelial cell morphology of colorectal cancer cell lines Cancer Research. 70: 4171-4171. DOI: 10.1158/1538-7445.Am10-4171  0.398
2010 Pene-Dumitrescu T, Smithgall TE. Abstract 3687: Expression of a Src-family kinase in CML cells induces resistance to imatinib in a kinase-dependent manner Cancer Research. 70: 3687-3687. DOI: 10.1158/1538-7445.Am10-3687  0.489
2010 Hellwig S, Zhang J, Filippakopoulos P, Salah E, Knapp S, Gray NS, Smithgall TE. Abstract 3683: Small molecule inhibitors of the Fes non-receptor tyrosine kinase Cancer Research. 70: 3683-3683. DOI: 10.1158/1538-7445.Am10-3683  0.413
2009 Schmaier AA, Zou Z, Kazlauskas A, Emert-Sedlak L, Fong KP, Neeves KB, Maloney SF, Diamond SL, Kunapuli SP, Ware J, Brass LF, Smithgall TE, Saksela K, Kahn ML. Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proceedings of the National Academy of Sciences of the United States of America. 106: 21167-72. PMID 19940238 DOI: 10.1073/Pnas.0906436106  0.346
2009 Meyn MA, Smithgall TE. Chemical genetics identifies c-Src as an activator of primitive ectoderm formation in murine embryonic stem cells. Science Signaling. 2: ra64. PMID 19825829 DOI: 10.1126/scisignal.2000311  0.334
2009 Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, Day BW, Lazo JS, Smithgall TE. Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. Acs Chemical Biology. 4: 939-47. PMID 19807124 DOI: 10.1021/Cb900195C  0.514
2009 Poe JA, Smithgall TE. HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. Journal of Molecular Biology. 394: 329-42. PMID 19781555 DOI: 10.1016/J.Jmb.2009.09.047  0.803
2009 Choi Y, Seeliger MA, Panjarian SB, Kim H, Deng X, Sim T, Couch B, Koleske AJ, Smithgall TE, Gray NS. N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor. The Journal of Biological Chemistry. 284: 29005-14. PMID 19679652 DOI: 10.1074/Jbc.M109.026633  0.798
2009 Shaffer JM, Hellwig S, Smithgall TE. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells. Biochemistry. 48: 4780-8. PMID 19382747 DOI: 10.1021/Bi900238F  0.747
2009 Iacob RE, Pene-Dumitrescu T, Zhang J, Gray NS, Smithgall TE, Engen JR. Conformational disturbance in Abl kinase upon mutation and deregulation. Proceedings of the National Academy of Sciences of the United States of America. 106: 1386-91. PMID 19164531 DOI: 10.1073/Pnas.0811912106  0.515
2009 Kanda S, Miyata Y, Kanetake H, Smithgall TE. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells. International Journal of Oncology. 34: 89-96. PMID 19082481 DOI: 10.3892/Ijo_00000132  0.394
2009 Shaffer JM, Smithgall TE. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer. Genes, Chromosomes & Cancer. 48: 272-84. PMID 19051325 DOI: 10.1002/Gcc.20638  0.69
2008 Pene-Dumitrescu T, Peterson LF, Donato NJ, Smithgall TE. An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259. Oncogene. 27: 7055-69. PMID 18794796 DOI: 10.1038/Onc.2008.330  0.529
2008 Chen S, O'Reilly LP, Smithgall TE, Engen JR. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core. Journal of Molecular Biology. 383: 414-23. PMID 18775435 DOI: 10.1016/J.Jmb.2008.08.040  0.544
2008 Engen JR, Wales TE, Hochrein JM, Meyn MA, Banu Ozkan S, Bahar I, Smithgall TE. Structure and dynamic regulation of Src-family kinases. Cellular and Molecular Life Sciences : Cmls. 65: 3058-73. PMID 18563293 DOI: 10.1007/S00018-008-8122-2  0.394
2008 Meyn MA, Smithgall TE. Small molecule inhibitors of Lck: the search for specificity within a kinase family. Mini Reviews in Medicinal Chemistry. 8: 628-37. PMID 18537718 DOI: 10.2174/138955708784534454  0.476
2008 Chen S, Dumitrescu TP, Smithgall TE, Engen JR. Abl N-terminal cap stabilization of SH3 domain dynamics. Biochemistry. 47: 5795-803. PMID 18452309 DOI: 10.1021/Bi800446B  0.489
2007 Trible RP, Emert-Sedlak L, Wales TE, Ayyavoo V, Engen JR, Smithgall TE. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor. Journal of Molecular Biology. 374: 121-9. PMID 17920628 DOI: 10.1016/J.Jmb.2007.09.009  0.824
2007 Kanda S, Miyata Y, Kanetake H, Smithgall TE. Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review). International Journal of Molecular Medicine. 20: 113-21. PMID 17549397 DOI: 10.3892/Ijmm.20.1.113  0.376
2007 Chen S, Brier S, Smithgall TE, Engen JR. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding. Protein Science : a Publication of the Protein Society. 16: 572-81. PMID 17327393 DOI: 10.1110/Ps.062631007  0.541
2007 Mitchell JL, Trible RP, Emert-Sedlak LA, Weis DD, Lerner EC, Applen JJ, Sefton BM, Smithgall TE, Engen JR. Functional characterization and conformational analysis of the Herpesvirus saimiri Tip-C484 protein. Journal of Molecular Biology. 366: 1282-93. PMID 17207813 DOI: 10.1016/J.Jmb.2006.12.026  0.798
2007 Pecquet C, Nyga R, Penard-Lacronique V, Smithgall TE, Murakami H, Régnier A, Lassoued K, Gouilleux F. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation. Oncogene. 26: 1577-85. PMID 16953222 DOI: 10.1038/Sj.Onc.1209949  0.491
2006 Chong YP, Chan AS, Chan KC, Williamson NA, Lerner EC, Smithgall TE, Bjorge JD, Fujita DJ, Purcell AW, Scholz G, Mulhern TD, Cheng HC. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases. The Journal of Biological Chemistry. 281: 32988-99. PMID 16959780 DOI: 10.1074/Jbc.M602951200  0.552
2006 Meyn MA, Wilson MB, Abdi FA, Fahey N, Schiavone AP, Wu J, Hochrein JM, Engen JR, Smithgall TE. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. The Journal of Biological Chemistry. 281: 30907-16. PMID 16912036 DOI: 10.1074/Jbc.M605902200  0.437
2006 Kanda S, Miyata Y, Kanetake H, Smithgall TE. Fibroblast growth factor-2 induces the activation of Src through Fes, which regulates focal adhesion disassembly. Experimental Cell Research. 312: 3015-22. PMID 16884713 DOI: 10.1016/J.Yexcr.2006.06.032  0.411
2006 Trible RP, Emert-Sedlak L, Smithgall TE. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. The Journal of Biological Chemistry. 281: 27029-38. PMID 16849330 DOI: 10.1074/Jbc.M601128200  0.838
2006 Delfino FJ, Shaffer JM, Smithgall TE. The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase. The Biochemical Journal. 399: 141-50. PMID 16792528 DOI: 10.1042/Bj20060194  0.737
2006 Hochrein JM, Wales TE, Lerner EC, Schiavone AP, Smithgall TE, Engen JR. Conformational features of the full-length HIV and SIV Nef proteins determined by mass spectrometry. Biochemistry. 45: 7733-9. PMID 16784224 DOI: 10.1021/Bi060438X  0.439
2006 Zhang Q, Thomas SM, Lui VW, Xi S, Siegfried JM, Fan H, Smithgall TE, Mills GB, Grandis JR. Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proceedings of the National Academy of Sciences of the United States of America. 103: 6901-6. PMID 16641105 DOI: 10.1073/Pnas.0509719103  0.335
2006 Delfino FJ, Stevenson H, Smithgall TE. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer. The Journal of Biological Chemistry. 281: 8829-35. PMID 16455651 DOI: 10.1074/Jbc.M507331200  0.427
2006 Hochrein JM, Lerner EC, Schiavone AP, Smithgall TE, Engen JR. An examination of dynamics crosstalk between SH2 and SH3 domains by hydrogen/deuterium exchange and mass spectrometry. Protein Science : a Publication of the Protein Society. 15: 65-73. PMID 16322569 DOI: 10.1110/Ps.051782206  0.432
2005 Lerner EC, Trible RP, Schiavone AP, Hochrein JM, Engen JR, Smithgall TE. Activation of the Src family kinase Hck without SH3-linker release. The Journal of Biological Chemistry. 280: 40832-7. PMID 16210316 DOI: 10.1074/Jbc.M508782200  0.823
2005 Meyn MA, Schreiner SJ, Dumitrescu TP, Nau GJ, Smithgall TE. SRC family kinase activity is required for murine embryonic stem cell growth and differentiation. Molecular Pharmacology. 68: 1320-30. PMID 15985613 DOI: 10.1124/Mol.104.010231  0.489
2004 Ye H, Choi HJ, Poe J, Smithgall TE. Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry. 43: 15775-84. PMID 15595833 DOI: 10.1021/Bi048712F  0.831
2004 Choi HJ, Smithgall TE. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. Journal of Molecular Biology. 343: 1255-68. PMID 15491611 DOI: 10.1016/J.Jmb.2004.09.015  0.554
2004 Laurent CE, Delfino FJ, Cheng HY, Smithgall TE. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly. Molecular and Cellular Biology. 24: 9351-8. PMID 15485904 DOI: 10.1128/Mcb.24.21.9351-9358.2004  0.418
2004 Choi HJ, Smithgall TE. HIV-1 Nef promotes survival of TF-1 macrophages by inducing Bcl-XL expression in an extracellular signal-regulated kinase-dependent manner. The Journal of Biological Chemistry. 279: 51688-96. PMID 15459189 DOI: 10.1074/Jbc.M410068200  0.485
2004 Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Grandis JR. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Research. 64: 6166-73. PMID 15342401 DOI: 10.1158/0008-5472.Can-04-0504  0.351
2004 Laurent CE, Smithgall TE. The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner. Experimental Cell Research. 299: 188-98. PMID 15302586 DOI: 10.1016/J.Yexcr.2004.05.010  0.424
2004 Cheng HY, Li P, David M, Smithgall TE, Feng L, Lieberman MW. Arsenic inhibition of the JAK-STAT pathway. Oncogene. 23: 3603-12. PMID 15116095 DOI: 10.1038/Sj.Onc.1207466  0.461
2004 Trible RP, Smithgall TE. HIV-1 Nef Alleles Show Differential Activation of Hematopoietic Cell Kinase in a Yeast Model System. Blood. 104: 3107-3107. DOI: 10.1182/Blood.V104.11.3107.3107  0.841
2003 Shangary S, Lerner EC, Zhan Q, Corey SJ, Smithgall TE, Baskaran R. Lyn regulates the cell death response to ultraviolet radiation through c-Jun N terminal kinase-dependent Fas ligand activation. Experimental Cell Research. 289: 67-76. PMID 12941605 DOI: 10.1016/S0014-4827(03)00234-9  0.372
2003 Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. The Journal of Biological Chemistry. 278: 31574-83. PMID 12771142 DOI: 10.1074/Jbc.M303499200  0.382
2003 Takashima Y, Delfino FJ, Engen JR, Superti-Furga G, Smithgall TE. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae. Biochemistry. 42: 3567-74. PMID 12653561 DOI: 10.1021/Bi0272499  0.514
2003 Shibata A, Laurent CE, Smithgall TE. The c-Fes protein-tyrosine kinase accelerates NGF-induced differentiation of PC12 cells through a PI3K-dependent mechanism. Cellular Signalling. 15: 279-88. PMID 12531426 DOI: 10.1016/S0898-6568(02)00089-X  0.394
2002 Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Oncogene. 21: 8075-88. PMID 12444544 DOI: 10.1038/Sj.Onc.1206008  0.409
2002 Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE, Skorski T. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. The Embo Journal. 21: 5766-74. PMID 12411494 DOI: 10.1093/Emboj/Cdf562  0.427
2002 Schreiner SJ, Schiavone AP, Smithgall TE. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. The Journal of Biological Chemistry. 277: 45680-7. PMID 12244095 DOI: 10.1074/jbc.M204255200  0.448
2002 Lerner EC, Smithgall TE. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nature Structural Biology. 9: 365-9. PMID 11976726 DOI: 10.1038/Nsb782  0.435
2002 Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR. Differential function of STAT5 isoforms in head and neck cancer growth control. Oncogene. 21: 2846-53. PMID 11973644 DOI: 10.1038/Sj.Onc.1205385  0.358
2001 Gmeiner WH, Xu I, Horita DA, Smithgall TE, Engen JR, Smith DL, Byrd RA. Intramolecular binding of a proximal PPII helix to an SH3 domain in the fusion protein SH3Hck : PPIIhGAP. Cell Biochemistry and Biophysics. 35: 115-26. PMID 11892787 DOI: 10.1385/Cbb:35:2:115  0.487
2001 Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene. 20: 6188-95. PMID 11593427 DOI: 10.1038/Sj.Onc.1204834  0.417
2001 Cheng HY, Schiavone AP, Smithgall TE. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells. Molecular and Cellular Biology. 21: 6170-80. PMID 11509660 DOI: 10.1128/Mcb.21.18.6170-6180.2001  0.485
2001 Briggs SD, Scholtz B, Jacque JM, Swingler S, Stevenson M, Smithgall TE. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. The Journal of Biological Chemistry. 276: 25605-11. PMID 11328823 DOI: 10.1074/Jbc.M103244200  0.509
2000 Lionberger JM, Wilson MB, Smithgall TE. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. The Journal of Biological Chemistry. 275: 18581-5. PMID 10849448 DOI: 10.1074/jbc.C000126200  0.461
2000 Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. The Journal of Biological Chemistry. 275: 24935-44. PMID 10823829 DOI: 10.1074/Jbc.M002383200  0.426
2000 Glover RT, Angiolieri M, Kelly S, Monaghan DT, Wang JY, Smithgall TE, Buller AL. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. The Journal of Biological Chemistry. 275: 12725-9. PMID 10777567 DOI: 10.1074/Jbc.275.17.12725  0.402
2000 Kanda S, Lerner EC, Tsuda S, Shono T, Kanetake H, Smithgall TE. The nonreceptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells. The Journal of Biological Chemistry. 275: 10105-11. PMID 10744691 DOI: 10.1074/Jbc.275.14.10105  0.433
2000 Briggs SD, Lerner EC, Smithgall TE. Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo. Biochemistry. 39: 489-95. PMID 10642173 DOI: 10.1021/Bi992504J  0.608
1999 Cheng H, Rogers JA, Dunham NA, Smithgall TE. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains. Molecular and Cellular Biology. 19: 8335-43. PMID 10567558 DOI: 10.1128/Mcb.19.12.8335  0.459
1999 Briggs SD, Smithgall TE. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts. The Journal of Biological Chemistry. 274: 26579-83. PMID 10473622 DOI: 10.1074/jbc.274.37.26579  0.474
1999 Engen JR, Gmeiner WH, Smithgall TE, Smith DL. Hydrogen exchange shows peptide binding stabilizes motions in Hck SH2. Biochemistry. 38: 8926-35. PMID 10413466 DOI: 10.1021/Bi982611Y  0.355
1999 Peters KL, Smithgall TE. Tyrosine phosphorylation enhances the SH2 domain-binding activity of Bcr and inhibits Bcr interaction with 14-3-3 proteins Cellular Signalling. 11: 507-514. PMID 10405761 DOI: 10.1016/S0898-6568(99)00021-2  0.479
1999 Engen JR, Smithgall TE, Gmeiner WH, Smith DL. Comparison of SH3 and SH2 domain dynamics when expressed alone or in an SH(3+2) construct: the role of protein dynamics in functional regulation. Journal of Molecular Biology. 287: 645-56. PMID 10092465 DOI: 10.1006/Jmbi.1999.2619  0.31
1998 Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N. The c-Fes family of protein-tyrosine kinases Critical Reviews in Oncogenesis. 9: 43-62. PMID 9754447 DOI: 10.1615/Critrevoncog.V9.I1.40  0.349
1998 Li J, Smithgall TE. Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation. The Journal of Biological Chemistry. 273: 13828-34. PMID 9593727 DOI: 10.1074/jbc.273.22.13828  0.37
1998 Zhang W, Smithgall TE, Gmeiner WH. Self-association and backbone dynamics of the hck SH2 domain in the free and phosphopeptide-complexed forms. Biochemistry. 37: 7119-26. PMID 9585523 DOI: 10.1021/Bi972077E  0.351
1998 Horita DA, Baldisseri DM, Zhang W, Altieri AS, Smithgall TE, Gmeiner WH, Byrd RA. Solution structure of the human Hck SH3 domain and identification of its ligand binding site Journal of Molecular Biology. 278: 253-265. PMID 9571048 DOI: 10.1006/Jmbi.1998.1690  0.324
1998 Nelson KL, Rogers JA, Bowman TL, Jove R, Smithgall TE. Activation of STAT3 by the c-Fes protein-tyrosine kinase Journal of Biological Chemistry. 273: 7072-7077. PMID 9507017 DOI: 10.1074/jbc.273.12.7072  0.38
1998 Zhang W, Smithgall TE, Gmeiner WH. Three-dimensional structure of the Hck SH2 domain in solution. Journal of Biomolecular Nmr. 10: 263-72. PMID 9390404 DOI: 10.1023/A:1018386217930  0.304
1997 Engen JR, Smithgall TE, Gmeiner WH, Smith DL. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry. 36: 14384-91. PMID 9398156 DOI: 10.1021/Bi971635M  0.472
1997 Nair SC, Toran EJ, Rimerman RA, Hjermstad S, Smithgall TE, Smith DF. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress & Chaperones. 1: 237-50. PMID 9222609 DOI: 10.1379/1466-1268(1996)001<0237:Apomci>2.3.Co;2  0.368
1997 Read RD, Lionberger JM, Smithgall TE. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region. The Journal of Biological Chemistry. 272: 18498-503. PMID 9218495 DOI: 10.1074/jbc.272.29.18498  0.315
1997 Briggs SD, Sharkey M, Stevenson M, Smithgall TE. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. The Journal of Biological Chemistry. 272: 17899-902. PMID 9218412 DOI: 10.1074/jbc.272.29.17899  0.545
1997 Zhang W, Smithgall TE, Gmeiner WH. Sequential assignment and secondary structure determination for the Src homology 2 domain of hematopoietic cellular kinase. Febs Letters. 406: 131-5. PMID 9109402 DOI: 10.1016/S0014-5793(97)00255-X  0.32
1997 Li J, Smithgall TE. Co-expression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues. The Journal of Biological Chemistry. 271: 32930-6. PMID 8955135 DOI: 10.1074/jbc.271.51.32930  0.409
1996 Rogers JA, Read RD, Li J, Peters KL, Smithgall TE. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues Journal of Biological Chemistry. 271: 17519-17525. PMID 8663427 DOI: 10.1074/jbc.271.29.17519  0.37
1996 Smithgall TE. SH2 and SH3 domains: potential targets for anti-cancer drug design. Journal of Pharmacological and Toxicological Methods. 34: 125-32. PMID 8573762 DOI: 10.1016/1056-8719(95)00082-7  0.441
1995 Briggs SD, Bryant SS, Jove R, Sanderson SD, Smithgall TE. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck. The Journal of Biological Chemistry. 270: 14718-24. PMID 7782336 DOI: 10.1074/jbc.270.24.14718  0.439
1995 Maru Y, Peters KL, Afar DEH, Shibuya M, Witte ON, Smithgall TE. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS Molecular and Cellular Biology. 15: 835-842. PMID 7529874 DOI: 10.1128/MCB.15.2.835  0.434
1993 Fang F, Ahmad S, Lei J, Klecker RW, Trepel JB, Smithgall TE, Glazer RI. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells. Biochemistry. 32: 6995-7001. PMID 8334128 DOI: 10.1021/Bi00078A026  0.396
1993 Hjermstad SJ, Briggs SD, Smithgall TE. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism. Biochemistry. 32: 10519-25. PMID 7691175 DOI: 10.1021/Bi00090A031  0.452
Show low-probability matches.